ISRCTN63778716已完成3 期
A randomised, multicentre phase III trial of combination chemotherapy +/- thoracic radiotherapy in the treatment of patients with stage III non-small cell lung cancer not eligible for radical therapy
Pierre Fabre Pharma Norden AB (Sweden)0 个研究点目标入组 352 人开始时间: 2009年5月29日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 352
研究概览
简要总结
- 2013 results in https://www.ncbi.nlm.nih.gov/pubmed/23963145 (added 21/01/2019) 2. 2014 results in https://www.ncbi.nlm.nih.gov/pubmed/24807158 (added 21/01/2019) 3. 2015 results in https://www.ncbi.nlm.nih.gov/pubmed/25481662 (added 21/01/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Chemo-naive patients with non-small cell lung cancer (NSCLC) locally advanced stage III, not candidates for radical radiotherapy and with no pleural effusion
- •2. Performance status (World Health Organization [WHO]) 0 - 2
- •3. Ability to understand oral and written study information
- •4. Both males and females, no age limit
- •5. S-creatinine less than 1.5 times upper reference limit, bilirubin and S-transaminase levels less than 2 times upper limits. Normal white blood-cell and platelet count.
排除标准
- •1. Other active malignancies
- •2. Pregnancy or breast feeding
研究者
相似试验
已完成
3 期
A phase III multi-centre randomised controlled trial to assess whether optimal supportive care alone (including dexamethasone) is as effective as optimal supportive care (including dexamethasone) plus whole brain radiotherapy in the treatment of patients with inoperable brain metastases from non-small cell lung canceron-small cell lung cancer with inoperable brain metastasesLung cancerCancerISRCTN13826061Medical Research Council (MRC) (UK)534
已完成
2 期
Cisplatin, capecitabine, and radiation therapy with or without cetuximab in treating patients with oesophageal cancerOesophageal cancerCancerISRCTN47718479Velindre NHS Trust (UK)420
已完成
3 期
Safety and efficacy trial of two doses of lurasidone in acutely psychotic subjects with schizophrenia (PEARL 3)Mental and Behavioural DisordersSchizophreniaISRCTN64695913Dainippon Sumitomo Pharma America Inc. (USA)480
已完成
不适用
Evaluating the feasibility and acceptability of a time limited anxiety in bipolar disorderBipolar disorderISRCTN84288072ancaster University (UK)72
已完成
不适用
A prospective, multicentre, randomised trial of carboplatin flat dosing vs. intrapatient dose escalation in first line chemotherapy of ovarian, fallopian tube and primary peritoneal cancersCancerISRCTN47645935niversity of Glasgow (UK)1,300